Janet Hardy

Honorary professor

Mater Medical Research Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Janet Hardy is an Honorary Professor at Mater Research in Australia. Her research focuses on the role of medicinal cannabis in oncology and palliative care, as demonstrated through her extensive work on clinical trials and feasibility studies. Recent articles by Professor Hardy explore topics including symptom control in advanced cancer, the efficacy of cannabidiol oil, and the quality use of corticosteroids in palliative settings.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Lyn R. Griffiths

Queensland University of Technology

AUSTRALIA

View details

Matt Zunk

Griffith University

AUSTRALIA

View details

Libby Sallnow

Post-doctoral Researcher and Guest Professor

Vrije Universiteit Brussel

BELGIUM

View details

Heidi Sutherland

Queensland University of Technology

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janet Hardy

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol

Has medicinal cannabis found a role in oncology/palliative care?

Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility study

Is there a role for hypnosis in palliative care?

Medicinal cannabis – has it found a place in palliative care?

Exploring potential anti-inflammatory effects of medicinal cannabis

Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)

Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer

Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer

Interests and conflicts when writing, reviewing and editing papers on voluntary assisted dying

Collaborators (4)

Lyn R. Griffiths

Matt Zunk

Libby Sallnow

Heidi Sutherland

Make your next move.